Original articleOutcomes of bariatric surgery in patients with body mass index <35 kg/m2
Section snippets
Methods
After institutional review board approval and following Health Insurance Portability and Accountability Act guidelines, we performed a retrospective review of a prospectively maintained database and medical chart review of 42 class I obese patients who had undergone a bariatric procedure from February 2000 to May 2010.
The population reviewed included 30 women and 12 men with a preoperative mean BMI of 33.9 kg/m2. The type of procedure was consensually agreed on by the patient and surgeon. Of
Results
Of our 42 patients, 1 patient had 6 years of follow-up, 14 completed 24 months of follow-up, 2 patients completed 18 months of follow-up, 6 patients completed >12 months of follow-up, 17 patients completed <12 months of follow-up, and 2 patients were lost to follow-up. Follow-up telephone calls were made in July 2010, and the following information was collected: current weight and improvement or remission of co-morbidities, such as diabetes, hypertension, dyslipidemia, obstructive sleep apnea,
Discussion
The mean preoperative BMI for our patient population was 33.9 kg/m2. In our patient series, the BMI ranged from 30 to 35 kg/m2, and all patients benefited from bariatric procedures, with the exception of 1 patient in the LAGB surgery group. We believe that the levels of illustrated improvement and remission of co-morbidities, along with the sustained weight loss, make this type of surgery suitable and safe for patients with a BMI of 30–35 kg/m2 with ≥1 co-morbidities, leading to an improvement
Conclusion
Bariatric surgery is the most effective treatment resulting in the long-term reduction of body weight and should at least be considered for all patients with a BMI >30 kg/m2 with existing obesity-related co-morbid conditions. Our study has shown that bariatric surgery is not only efficacious in the treatment of diabetes mellitus but also leads to improvement or remission of other obesity-related co-morbidities. From our series of patients, it appears that this type of surgery can be safely
Disclosures
Dr. Rosenthal received educational grants from Ethicon, Covidien, Storz, and Synovis; is an advisory board member, consultant, and speaker for Ethicon; an advisory board member and stockholder for Safestich Inc; and advisory board member for Reshape and Vybrint. Dr. Szomstein is a consultant for Ethicon and Covidien. Drs. Gianos, Abdemur, Fendrich, and Gari have no disclosures to report.
References (13)
- et al.
Obesity, mortality and cardiovascular disease in the Münster Heart Study (PROCAM)
Atherosclerosis
(1999) - et al.
Duodenal-jejunal bypass for the treatment of type 2 diabetes in patients with body mass index of 22–34 kg/m2: a report of two cases
Surg Obes Relat Dis
(2007) Etiology and natural history of obesity
Obesity and overweight
Diabetes
- et al.
Body mass index and mortality in a prospective cohort of US adults
N Engl J Med
(1999)
Cited by (18)
Evaluating the safety of bariatric surgery for weight loss in class I obesity: A propensity-matched analysis of North American data
2019, Surgery for Obesity and Related DiseasesBody image of women with type I obesity after 2–5 years of subtotal gastrectomy vertical
2017, Revista Mexicana de Trastornos AlimentariosBariatric surgery in class i obesity (body mass index 30-35 kg/m <sup>2</sup>)
2013, Surgery for Obesity and Related DiseasesCitation Excerpt :There was also variability in the method of weight and co-morbidity reporting. Laparoscopic adjustable gastric banding, sleeve gastrectomy, gastric bypass, and biliopancreatic diversion are all represented in the current literature (Table 3) [31–46]. Weight loss.
Reversal of gastric plication after laparoscopic adjustable gastric banded plication
2013, Surgery for Obesity and Related DiseasesCitation Excerpt :At 2 months of follow-up, she had reached a %EWL of 71.2%, an increase of 6.6% in previous 2 months, without any band adjustment. Bariatric surgery has emerged as the most effective and sustainable weight loss option for obese patients and resolution of associated co-morbidities [2]. Restrictive bariatric procedures such as laparoscopic adjustable gastric banding (LAGB) and laparoscopic sleeve gastrectomy are gaining popularity because of the lower complication rates compared with malabsorptive procedures [3].
Osteoarthritis and cardiovascular comorbidity.
2012, Seminarios de la Fundacion Espanola de Reumatologia